Merck’s vaccine investment nears $1bn
Merck & Co has earmarked nearly $1bn in investment funding to boost its quality and manufacturing capacity in vaccines, said chief executive Dick Clark on the firm’s fourth-quarter results call.
Archives for February 9, 2009
Indian river pollution sparks call for change
Researchers have estimated that a pharmaceutical waste water treatment plant is pumping up to 45kg a day of ciprofloxacin into an Indian river, which could have grave consequences for the ecosystem.
Millipore moves for Guava to boost bioscience
Millipore hopes its $23m (€18m) swoop for Guava Technologies will draw attention away from the underperformance of its bioprocess division, revenue from which fell 6 per cent in Q4 to $214m (€165m) and 2 per cent for 2008 overall.
GAC and Zuellig Pharma renew distribution deal
Logistics specialist GAC says its Shipping and Cargo unit has signed a new contract with Philipino drug distributor Zuellig Pharma.
Hacked wireless delivery devices could release fatal dose
Researchers have raised concerns that wirelessly activated drug delivery devices could be hacked to steal personal information or release potentially fatal doses of a therapeutic.
Pharma Phacts
Deuteration may help drug development
New research suggests that deuteration, the replacement of hydrogen atoms with heavier forms, can alter an API's crystallisation properties and help drugmakers make better more effective drugs.
Under pressure MDS may sell off divisions
MDS has formed a special committee to improve shareholder value following poor results and pressure from investors to sell some of its business units, which include a CRO division.
Russia’s clinical sector on the up
Russia approved 615 clinical trials last year, a 9 per cent increase over 2007, lending weight to the notion that the country is becoming a global hub for clinical testing.